| 000 | 01891 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517120845.0 | ||
| 264 | 0 | _c20170929 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-016-2813-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetkar, Imran | |
| 245 | 0 | 0 |
_aDARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. _h[electronic resource] |
| 260 |
_bBMC cancer _c10 2016 |
||
| 300 |
_a770 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xradiotherapy |
| 650 | 0 | 4 | _aChemoradiotherapy |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 |
_aDeglutition Disorders _xetiology |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xradiotherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aRadiation Injuries _xetiology |
| 650 | 0 | 4 |
_aRadiotherapy, Intensity-Modulated _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSquamous Cell Carcinoma of Head and Neck |
| 700 | 1 | _aRooney, Keith | |
| 700 | 1 | _aRoe, Justin W G | |
| 700 | 1 | _aPatterson, Joanne M | |
| 700 | 1 | _aBernstein, David | |
| 700 | 1 | _aTyler, Justine M | |
| 700 | 1 | _aEmson, Marie A | |
| 700 | 1 | _aMorden, James P | |
| 700 | 1 | _aMertens, Kathrin | |
| 700 | 1 | _aMiles, Elizabeth | |
| 700 | 1 | _aBeasley, Matthew | |
| 700 | 1 | _aRoques, Tom | |
| 700 | 1 | _aBhide, Shreerang A | |
| 700 | 1 | _aNewbold, Kate L | |
| 700 | 1 | _aHarrington, Kevin J | |
| 700 | 1 | _aHall, Emma | |
| 700 | 1 | _aNutting, Christopher M | |
| 773 | 0 |
_tBMC cancer _gvol. 16 _gno. 1 _gp. 770 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-016-2813-0 _zAvailable from publisher's website |
| 999 |
_c26494780 _d26494780 |
||